149 related articles for article (PubMed ID: 33350797)
1. Pre-radiofrequency ablation MRI imaging features predict the local tumor progression in hepatocellular carcinoma.
Hu Z; Yu N; Wang H; Li S; Yan J; Zhang G
Medicine (Baltimore); 2020 Dec; 99(52):e23924. PubMed ID: 33350797
[TBL] [Abstract][Full Text] [Related]
2. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
[TBL] [Abstract][Full Text] [Related]
4. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
5. MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection.
Sun HT; Zhang SL; Liu K; Zhou JJ; Wang XX; Shen TT; Song XH; Guo YL; Wang XL
J Magn Reson Imaging; 2019 Aug; 50(2):397-409. PubMed ID: 30589158
[TBL] [Abstract][Full Text] [Related]
6. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.
Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
[TBL] [Abstract][Full Text] [Related]
7. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
8. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
11. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
13. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
14. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.
Fukuda K; Mori K; Hasegawa N; Nasu K; Ishige K; Okamoto Y; Shiigai M; Abei M; Minami M; Hyodo I
Jpn J Radiol; 2019 Jul; 37(7):555-563. PubMed ID: 31102138
[TBL] [Abstract][Full Text] [Related]
15. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
[TBL] [Abstract][Full Text] [Related]
16. Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation.
Lv X; Chen M; Kong C; Shu G; Meng M; Ye W; Cheng S; Zheng L; Fang S; Chen C; Wu F; Weng Q; Tu J; Zhao Z; Ji J
Eur J Radiol; 2021 Nov; 144():109955. PubMed ID: 34600237
[TBL] [Abstract][Full Text] [Related]
17. Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Murawaki Y; Kakite S; Yamashita E
J Gastroenterol; 2013 Nov; 48(11):1283-92. PubMed ID: 23338488
[TBL] [Abstract][Full Text] [Related]
18. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid-enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma.
Wang R; Xu H; Chen W; Jin L; Ma Z; Wen L; Wang H; Cao K; Du X; Li M
Front Oncol; 2023; 13():975216. PubMed ID: 36816925
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.
Sheng RF; Zeng MS; Ren ZG; Ye SL; Zhang L; Chen CZ
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):603-12. PubMed ID: 26663008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
